HemaSphere (Oct 2022)

T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma

  • Alison J. Moskowitz,
  • Gunjan Shah,
  • Heiko Schöder,
  • Nivetha Ganesan,
  • Helen Hancock,
  • Theresa Davey,
  • Leslie Perez,
  • Samia Sohail,
  • Alayna Santarosa,
  • Charisse Capadona,
  • Brittney Munayirji,
  • Anita Kumar,
  • Oscar Lahoud,
  • Connie Batlevi,
  • Paul Hamlin,
  • David J. Straus,
  • Colette Owens,
  • Philip Caron,
  • Andrew Intlekofer,
  • Audrey Hamilton,
  • Steven Horwitz,
  • Lorenzo Falchi,
  • William Johnson,
  • Lia Palomba,
  • Ariela Noy,
  • Matthew Matasar,
  • Georgios Pongas,
  • Gilles Salles,
  • Santosha Vardhana,
  • Beatriz Wills Sanin,
  • Joachim Yahalom,
  • Ahmet Dogan,
  • Andrew Zelenetz,
  • Craig H. Moskowitz

DOI
https://doi.org/10.1097/01.HS9.0000890964.54059.2c
Journal volume & issue
Vol. 6
pp. 45 – 46

Abstract

Read online

No abstracts available.